Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.

Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006 Aug 03; 355(5):467-77.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.